Product Information

Celgene currently has six products registered in Australia.   In this section of the website, you will find information regarding our approved products, including Consumer Medicine Information and the Product Information leaflets.

  • The Consumer Medicine Information leaflets (CMIs) provide important information for patients taking our approved products.
  • The Product Information (PI) is a description for health care professionals of a medicinal product including recommendations for its use.

Please note that this information is specific to Australia and is not intended to replace the advice of a qualified doctor or pharmacist. If you have a health concern, please consult your health care professional. 


 

Product name
 
Product Information linkConsumer Medicine Information link
ISTODAX® (romidepsin)Product Information linkConsumer Medicine Information link
OTEZLA® (apremilast)Product Information linkConsumer Medicine Information link
POMALYST® (pomalidomide)Product Information linkConsumer Medicine Information link
Revlimid® (lenalidomide)Product Information linkConsumer Medicine Information link
THALOMID® (thalidomide)Product Information linkConsumer Medicine Information link
VIDAZA® (azacitidine)Product Information linkConsumer Medicine Information link

ABRAXANE®, ISTODAX®, OTEZLA®, POMALYST®, REVLIMID®, THALOMID® , VIDAZA® are registered trademarks of Celgene Corporation.

Reporting of side effects

Like all medicines, Celgene products can have side effects, although not everybody gets them. Sometimes they are serious, most of the time they are not. You may need medical attention if you get some of the side

Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking a Celgene product.

To report a side effect experienced while taking a Celgene product, please provide the details to the Celgene Australia Drug Safety team:

Email: drugsafety-anz@celgene.com

Phone (Toll free):  Australia – 1800 235 436, New Zealand – 0800 526 529

Fax (Toll free):  Australia – 1800 455 125, New Zealand – 0800 403 620

 

* Abraxane is marketed in Australia by Specialised Therapeutics Australia Pty Ltd.